Present correction good for markets, will spur buying going forward: Devang Mehta, Anand Rathi Financial Services
"The events the market was looking forward to are now out of the way. Besides, the run-up had been too sharp; hence, the correction."

ET Now: It has been fairly listless for the markets and this has been the trend for the past many days. What do you think is leading to this nervous approach?
Devang Mehta: There are a couple of reasons which can be attributed to the current nervousness. The market was getting prepared for specific events, and now those events are out of the way. Besides, probably the run-up in the market had been too sharp. So this correction and consolidation happening in the market, currently in stocks as well as in sectors, were perhaps in order.
It will in fact give a lot of strength to the markets. Currently, a lot of inquires are being made by the participants who are sitting on the sidelines, or had missed the bus earlier. So, at every level going forward, there would be buying coming in. I guess that for two or three more days, there can still be a little bit of nervousness, as there is lack of volumes as well participation at the current point.
But this augurs well for the market overall when we consider that it will only impart strength in the long haul.
ET Now: The NPP has brought more drugs under the price control regime. We saw some counters from the pharma space taking a big knock yesterday. Do you see more pressure building up in this space?
Devang Mehta: The pharma space, in the last few days barring yesterday, had also run up quite a bit. This is true of some of the stocks which were not performing earlier when the cyclicals were doing well. Some of the stocks had started to perform well during the last three-four days when there was some correction in the market.
So, yes again, probably defensives would tend to be slightly on the lower side in the coming days, and banks as well as cyclicals will start doing well. Probably pharma is one space where there is a lot of uncertainty at this time. So, new buyers can stay away from the sector at this point.
ET Now: It clearly seems that recapitalisation is a hot topic when it comes to some of the PSU banks. We are seeing a little bit of steam in the space as well. What is your sense when it comes to the PSUs vis-à-vis the private banking names? Which are the banking stocks that you like?
Devang Mehta: In the PSU banks space, we have started to like a couple of large cap names. SBI and BOB would top our list. We feel that the price differential between private large cap banks and PSU banks is still huge. Bank of Baroda is slated to do very well given the numbers that it posted last time. There is an improving trajectory from SBI as well.
ET Now: In IT, some select midcap stocks are doing very well. The result season is just starting. What are you watching out for? Give us one top large cap IT name in terms of results, and one top midcap IT name.
Devang Mehta: Probably TCS would be the top pick over here in the large cap space. The way the company has performed over the past 10-12 quarters has been amazing. The consistency has been superb. So, TCS would be our top pick here, though it is a little bit expensive on the valuation front.
Among midcaps, Tech Mahindra and MindTree come to the mind. If there is only one stock to pick, then I would go for Tech Mahindra. With the improving trajectory that the company has shown in the past few quarters, we find no reason why the stock would not continue to perform well. So we feel that Tech Mahindra would be qualifying as our top pick in terms of a large-sized midcap stock.
ET Now: It certainly is a very large-sized midcap stock. I mean Tech Mahindra has a market cap of Rs 47,000 crore. So let me reframe that question. Among small cap IT stocks, what do you watch out for? MindTree would probably fit the bill with its Rs 7,000-8,000 crore of market cap. But what about some of the other smaller names that people do not usually talk about?
Devang Mehta: As you said, MindTree would be a particularly mid-sized stock, but among the smaller names, Hexaware would tend to do well. The stock has been a consistent performer over the past few quarters. Now, given the improving global environment, Hexaware would surely tend to benefit.
ET Now: Are you taking any risky bets? Are you advising your clients to take risky bets, like those stocks where the chances of not doing well and becoming multi-bagger are equal?
Devang Mehta: One stock came up just 10-15 days back; it is called Apar Industries. This company is a leader in the segment of transformer oil. It has the highest market share there. The valuations too are very supportive at this point of time, and if at all we are talking about the recovery of the capex cycle and the investment cycle, the order flow for the transformer companies would simply bulge.
Therefore, this company would be an indirect beneficiary. The finances of this company have changed for the better in the last two-three quarters. So we feel that Apar Industries could return 50%, 60%, or 70% in a year.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.